Table 3.
Relationship between Cognalyzer® version 1 psychoactive effect (PE) levels (log transformed) and the modified Drug Effects Questionnaire (DEQ) scores in the PP population (n = 41)
| Drug Effects Questionnaire vs. Cognalyzer® V1 PE levels | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Variables | DEQ question 1—feel | DEQ question 2—high | DEQ question 3—dislike | ||||||
| Coefficient | Standard error | p value | Coefficient | Standard error | p value | Coefficient | Standard error | p value | |
| (Intercept) | 9.11 | 1.15 | < 0.001 | 9.06 | 1.19 | < 0.001 | 2.5 | 1.48 | 0.093 |
| Cognalyzer® V1 THC level | 0.38 | 0.23 | 0.102 | 0.26 | 0.22 | 0.25 | 0.38 | 0.27 | 0.167 |
| Time 0.5 h | − 0.64 | 0.32 | 0.045 | − 0.6 | 0.31 | 0.052 | − 0.54 | 0.38 | 0.156 |
| Time 1 h | − 1.15 | 0.36 | 0.002 | − 1.24 | 0.35 | < 0.001 | − 0.4 | 0.43 | 0.357 |
| Time 1.5 h | − 2.57 | 0.34 | < 0.001 | − 2.98 | 0.33 | < 0.001 | − 0.77 | 0.4 | 0.058 |
| Time 2 h | − 3.82 | 0.36 | < 0.001 | − 4.14 | 0.35 | < 0.001 | − 0.77 | 0.43 | 0.077 |
| Time 2.5 h | − 4.56 | 0.37 | < 0.001 | − 4.85 | 0.36 | < 0.001 | − 1.04 | 0.44 | 0.018 |
| Time 3 h | − 5.38 | 0.37 | < 0.001 | − 5.58 | 0.35 | < 0.001 | − 1.37 | 0.43 | 0.002 |
| Time 3.5 h | − 6.35 | 0.39 | < 0.001 | − 6.65 | 0.37 | < 0.001 | − 1.25 | 0.46 | 0.007 |
| Time 4 h | − 7.03 | 0.4 | < 0.001 | − 7.05 | 0.39 | < 0.001 | − 1.86 | 0.48 | < 0.001 |
| Age | − 0.05 | 0.03 | 0.153 | − 0.05 | 0.04 | 0.146 | 0 | 0.04 | 0.976 |
| Gender-male | 0.09 | 0.48 | 0.851 | 0.14 | 0.49 | 0.779 | − 0.64 | 0.62 | 0.309 |
| Cognalyzer® PE level:time 0.5 h | − 0.23 | 0.3 | 0.453 | 0.03 | 0.29 | 0.914 | − 0.67 | 0.36 | 0.063 |
| Cognalyzer® PE level:time 1 h | 0.24 | 0.34 | 0.473 | 0.31 | 0.33 | 0.349 | 0.07 | 0.4 | 0.863 |
| Cognalyzer® PE level:time 1.5 h | − 0.25 | 0.27 | 0.356 | − 0.31 | 0.26 | 0.236 | − 0.37 | 0.32 | 0.257 |
| Cognalyzer® PE level:time 2 h | − 0.53 | 0.29 | 0.068 | − 0.53 | 0.28 | 0.06 | − 0.44 | 0.34 | 0.203 |
| Cognalyzer® PE level:time 2.5 h | − 0.46 | 0.29 | 0.114 | − 0.43 | 0.28 | 0.127 | − 0.67 | 0.35 | 0.054 |
| Cognalyzer® PE level:time 3 h | − 0.45 | 0.31 | 0.147 | − 0.42 | 0.3 | 0.162 | − 0.74 | 0.37 | 0.046 |
| Cognalyzer® PE level:time 3.5 h | − 0.78 | 0.33 | 0.019 | − 0.71 | 0.32 | 0.027 | − 0.72 | 0.39 | 0.069 |
| Cognalyzer® PE level:time 4 h | − 0.78 | 0.3 | 0.009 | − 0.63 | 0.29 | 0.028 | − 0.72 | 0.35 | 0.043 |
| Drug Effects Questionnaire vs. Cognalyzer® V1 PE levels | ||||||
|---|---|---|---|---|---|---|
| Variables | DEQ question 4—like | DEQ question 5—more of drug | ||||
| Coefficient | Standard error | p value | Coefficient | Standard error | p value | |
| (Intercept) | 6.94 | 1.66 | < 0.001 | 1.46 | 1.77 | 0.411 |
| Cognalyzer® V1 THC level | 0.95 | 0.35 | 0.007 | 0.06 | 0.3 | 0.831 |
| Time 0.5 h | − 0.23 | 0.48 | 0.64 | − 0.05 | 0.41 | 0.913 |
| Time 1 h | − 0.53 | 0.54 | 0.332 | 0.18 | 0.47 | 0.701 |
| Time 1.5 h | − 1.2 | 0.51 | 0.021 | − 0.31 | 0.44 | 0.479 |
| Time 2 h | − 2.08 | 0.55 | < 0.001 | − 0.63 | 0.47 | 0.185 |
| Time 2.5 h | − 2.8 | 0.56 | < 0.001 | − 0.72 | 0.48 | 0.134 |
| Time 3 h | − 3.48 | 0.55 | < 0.001 | − 0.48 | 0.47 | 0.316 |
| Time 3.5 h | − 4.76 | 0.59 | < 0.001 | − 0.46 | 0.5 | 0.366 |
| Time 4 h | − 5.37 | 0.61 | < 0.001 | − 1.1 | 0.52 | 0.036 |
| Age | − 0.01 | 0.05 | 0.841 | − 0.01 | 0.05 | 0.876 |
| Gender-male | 1.12 | 0.69 | 0.114 | 1.47 | 0.74 | 0.055 |
| Cognalyzer® PE level:time 0.5 h | − 0.77 | 0.46 | 0.094 | − 0.23 | 0.39 | 0.56 |
| Cognalyzer® PE level:time 1 h | − 0.52 | 0.51 | 0.31 | 0.33 | 0.44 | 0.451 |
| Cognalyzer® PE level:time 1.5 h | − 0.75 | 0.41 | 0.071 | − 0.13 | 0.35 | 0.705 |
| Cognalyzer® PE level:time 2 h | − 1.26 | 0.44 | 0.004 | − 0.22 | 0.38 | 0.562 |
| Cognalyzer® PE level:time 2.5 h | − 1.13 | 0.44 | 0.011 | − 0.53 | 0.38 | 0.162 |
| Cognalyzer® PE level:time 3 h | − 1.06 | 0.47 | 0.025 | − 0.34 | 0.4 | 0.392 |
| Cognalyzer® PE level:time 3.5 h | − 1.89 | 0.5 | < 0.001 | − 0.3 | 0.43 | 0.49 |
| Cognalyzer® PE level:time 4 h | − 1.77 | 0.45 | < 0.001 | − 0.63 | 0.39 | 0.104 |